Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Transcat ( (TRNS) ) is now available.
On March 6, 2026, Transcat’s board appointed industrial and technology veteran Jaime Irick as president and chief executive officer, with his tenure and board service to begin on March 29, 2026, succeeding long-time CEO Lee D. Rudow, who will move to a senior advisory role through March 2027. The company formalized Irick’s three-year employment agreement, set his initial compensation package, and confirmed that his predecessor’s departure was not due to any dispute over Transcat’s operations or governance.
Irick brings a track record of growth, integration and operational execution from roles at Pittsburgh Paints Company, PPG Industries, Brunswick’s Life Fitness unit and General Electric, experience the board says aligns with Transcat’s strategy of scaling calibration services and strengthening its position in critical regulated industries. On March 6, 2026, Transcat also approved higher fiscal 2027 compensation for chief financial officer Thomas L. Barbato and adopted updated indemnification agreements for directors and executives, moves that underscore its effort to reinforce leadership stability and governance protections as it pursues further growth.
The most recent analyst rating on (TRNS) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Transcat stock, see the TRNS Stock Forecast page.
Spark’s Take on TRNS Stock
According to Spark, TipRanks’ AI Analyst, TRNS is a Neutral.
The score is driven primarily by solid underlying fundamentals and a constructive earnings update (reaffirmed organic growth guidance, strong revenue/margin trends). This is tempered by weaker TTM net/FCF momentum and higher leverage, while valuation is a notable headwind due to the elevated P/E; technicals are neutral overall.
To see Spark’s full report on TRNS stock, click here.
More about Transcat
Transcat, Inc., based in Rochester, N.Y., is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, CMMS and pipette services. The company focuses on highly regulated sectors such as life sciences, including pharmaceutical, biotechnology, medical device and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities.
It delivers periodic on-site, mobile, pickup and delivery, and in-house calibration services across the United States, Puerto Rico, Canada and Ireland, and also operates embedded labs at customer sites. Transcat additionally runs a value-added distribution business that markets, sells and rents test, measurement and control instruments, leveraging its combined service and distribution platform to drive organic growth and targeted acquisitions.
Average Trading Volume: 141,895
Technical Sentiment Signal: Hold
Current Market Cap: $659.5M
For an in-depth examination of TRNS stock, go to TipRanks’ Overview page.